These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22537564)

  • 1. A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease.
    Singh RG; Singh TB; Kumar R; Dwivedi US; Moorthy KN; Kumar N
    J Altern Complement Med; 2012 May; 18(5):427-8. PubMed ID: 22537564
    [No Abstract]   [Full Text] [Related]  

  • 2. Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study.
    Singh RG; Behura SK; Kumar R
    J Assoc Physicians India; 2010 May; 58():286-9. PubMed ID: 21117346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus.
    Assimos DG
    J Urol; 2015 Mar; 193(3):897-8. PubMed ID: 25765394
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Editorial Comment on Randomized and Double-Blinded Clinical Trial of the Safety and Calcium Kidney Stone Dissolving Efficacy of Lapis Judaicus: D. G. Assimos J Urol 2015;193:897-898.
    Faridi P; Mohagheghzadeh A; Roozbeh J
    J Urol; 2015 Jul; 194(1):267. PubMed ID: 25862236
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypocitraturia despite potassium citrate tablet supplementation.
    Shenoy C
    MedGenMed; 2006 Jul; 8(3):8. PubMed ID: 17406150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolit in the treatment and prophylaxis of nephrolithiasis].
    Borisov VV; Koptev VV; Enaleeva SK; Demerza IuA
    Urologiia; 2004; (2):38-40. PubMed ID: 15114752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.
    Tosukhowong P; Yachantha C; Sasivongsbhakdi T; Ratchanon S; Chaisawasdi S; Boonla C; Tungsanga K
    Urol Res; 2008 Aug; 36(3-4):149-55. PubMed ID: 18560820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocitraturia: a common but not well-known cause of nephrolithiasis.
    Bos S; Nap RR; Wouters RS; van der Kleij FG
    Neth J Med; 2014 Dec; 72(10):545-7. PubMed ID: 26219761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis.
    Pak CY; Peterson RD; Poindexter J
    J Urol; 2002 Jul; 168(1):31-4. PubMed ID: 12050486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS].
    Drori T; Abu-Ghanem Y; Kleinmann N; Shvero A; Winkler HZ; Zilberman DE
    Harefuah; 2019 Dec; 158(12):774-777. PubMed ID: 31823528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of renal lithiasis with potassium citrate.
    Spivacow FR; Negri AL; Polonsky A; Del Valle EE
    Urology; 2010 Dec; 76(6):1346-9. PubMed ID: 20399488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney stones: pathophysiology and medical management.
    Moe OW
    Lancet; 2006 Jan; 367(9507):333-44. PubMed ID: 16443041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
    He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
    J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food supplementation based on potassium citrate, magnesium and probiotics reduces crystalluria in patients undergoing endourological surgery for stone disease: report from a pilot study.
    Vittori M; Signoretti M; Cipriani C; Antonucci M; Ferraro PM; Bove P
    Urolithiasis; 2022 Oct; 50(5):651-652. PubMed ID: 35913551
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus.
    Faridi P; Seradj H; Mohammadi-Samani S; Vossoughi M; Mohagheghzadeh A; Roozbeh J
    J Ethnopharmacol; 2014 Oct; 156():82-7. PubMed ID: 25193008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of potassium citrate in the prophylaxis of urinary lithiasis].
    Jiménez Verdejo A; Arrabal Martín M; Miján Ortiz JL; Hita Rosino E; Palao Yago F; Zuluaga Gómez A
    Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium citrate tablets for nephrolithiasis.
    Med Lett Drugs Ther; 1986 Apr; 28(712):48. PubMed ID: 3959989
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
    Whitson PA; Pietrzyk RA; Jones JA; Nelman-Gonzalez M; Hudson EK; Sams CF
    J Urol; 2009 Nov; 182(5):2490-6. PubMed ID: 19765769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.